Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LENSAR, Inc. stock logo
LNSR
LENSAR
$3.32
-3.2%
$3.83
$1.80
$5.30
$37.85M0.4740,187 shs75,947 shs
Nephros, Inc. stock logo
NEPH
Nephros
$2.19
$2.52
$1.13
$4.04
$23.08M1.318,971 shs4,588 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$18.68
+1.2%
$17.66
$14.51
$22.99
$65.57M0.67,894 shs6,395 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LENSAR, Inc. stock logo
LNSR
LENSAR
+5.21%+9.24%-3.11%-10.68%+28.46%
Nephros, Inc. stock logo
NEPH
Nephros
0.00%+10.05%-0.90%-38.83%+51.06%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.22%-1.70%+7.20%-14.22%+15.52%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LENSAR, Inc. stock logo
LNSR
LENSAR
2.9734 of 5 stars
3.55.00.00.02.62.50.0
Nephros, Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LENSAR, Inc. stock logo
LNSR
LENSAR
3.00
Buy$8.00140.96% Upside
Nephros, Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A

Current Analyst Ratings

Latest PDEX, NEPH, and LNSR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/19/2024
LENSAR, Inc. stock logo
LNSR
LENSAR
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$8.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LENSAR, Inc. stock logo
LNSR
LENSAR
$42.16M0.90N/AN/A$2.97 per share1.12
Nephros, Inc. stock logo
NEPH
Nephros
$14.24M1.62N/AN/A$0.80 per share2.74
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.09M1.42$2.26 per share8.26$8.91 per share2.10

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LENSAR, Inc. stock logo
LNSR
LENSAR
-$14.38M-$1.79N/AN/A-34.11%-40.53%-21.83%5/20/2024 (Estimated)
Nephros, Inc. stock logo
NEPH
Nephros
-$1.58M-$0.15N/AN/A-11.06%-18.25%-14.29%5/8/2024 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.7524.91N/A5.59%8.97%5.40%5/2/2024 (Estimated)

Latest PDEX, NEPH, and LNSR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/7/2024Q4 2023
Nephros, Inc. stock logo
NEPH
Nephros
N/A-$0.06-$0.06-$0.06N/A$3.25 million    
3/4/202412/31/2023
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.22-$0.22N/A-$0.35N/A$12.11 million    
2/8/2024Q2 2024
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/A$0.14+$0.14$0.14N/A$12.59 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
Nephros, Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
3.99
2.64
Nephros, Inc. stock logo
NEPH
Nephros
N/A
3.98
2.81
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.26
3.66
2.16

Ownership

Institutional Ownership

CompanyInstitutional Ownership
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
Nephros, Inc. stock logo
NEPH
Nephros
41.10%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%

Insider Ownership

CompanyInsider Ownership
LENSAR, Inc. stock logo
LNSR
LENSAR
38.52%
Nephros, Inc. stock logo
NEPH
Nephros
4.10%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
LENSAR, Inc. stock logo
LNSR
LENSAR
13011.40 million7.01 millionOptionable
Nephros, Inc. stock logo
NEPH
Nephros
3110.54 million10.11 millionNot Optionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.51 million2.02 millionNot Optionable

PDEX, NEPH, and LNSR Headlines

SourceHeadline
How to use Samsung Dex for gamingHow to use Samsung Dex for gaming
msn.com - April 26 at 8:09 AM
What is Samsung DeX and how does it work?What is Samsung DeX and how does it work?
msn.com - April 23 at 11:18 AM
Pro-Dex Inc. (co)Pro-Dex Inc. (co)
money.usnews.com - April 19 at 10:51 AM
Pro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Decrease in Short InterestPro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Decrease in Short Interest
marketbeat.com - April 13 at 11:20 AM
Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200-Day Moving Average of $17.72Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200-Day Moving Average of $17.72
marketbeat.com - April 11 at 3:14 AM
AutoPro X accessory will bring Samsung DeX to your vehicleAutoPro X accessory will bring Samsung DeX to your vehicle
msn.com - April 9 at 10:27 AM
Vicarious Surgical Stock (NYSE:RBOT), Quotes and News SummaryVicarious Surgical Stock (NYSE:RBOT), Quotes and News Summary
benzinga.com - April 2 at 10:06 PM
Monogram Orthopaedics reports FY resultsMonogram Orthopaedics reports FY results
seekingalpha.com - March 15 at 3:03 PM
The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Dont Inspire ConfidenceThe Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence
finance.yahoo.com - February 22 at 2:16 PM
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month ResultsPro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
finance.yahoo.com - February 8 at 7:45 PM
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five yearsPro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five years
finance.yahoo.com - January 26 at 7:04 PM
Is Pro-Dex, Inc.s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?
finance.yahoo.com - December 30 at 4:00 PM
Dex Carvey Dies: Comedian Son Of Dana Carvey Was 32Dex Carvey Dies: Comedian Son Of Dana Carvey Was 32
deadline.com - November 22 at 4:30 AM
PowerDEX Launches: CEX Performance Meets DEX FreedomPowerDEX Launches: CEX Performance Meets DEX Freedom
coinspeaker.com - November 21 at 4:16 PM
Here’s Why You Should Consider Buying Pro-Dex (PDEX) SharesHere’s Why You Should Consider Buying Pro-Dex (PDEX) Shares
finance.yahoo.com - November 14 at 2:04 AM
Pro-Dex Inc PDEXPro-Dex Inc PDEX
morningstar.com - November 10 at 12:39 PM
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter ResultsPro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
finance.yahoo.com - November 2 at 6:52 PM
Pro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000Pro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000
finance.yahoo.com - November 2 at 6:52 PM
Stock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastStock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
finanznachrichten.de - October 26 at 10:18 AM
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastPro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
finance.yahoo.com - October 26 at 10:18 AM
Pro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year ResultsPro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year Results
finance.yahoo.com - October 15 at 12:00 AM
Pro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year ResultsPro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year Results
finance.yahoo.com - October 13 at 7:19 PM
North American Morning Briefing: S&P 500 Futures -2-North American Morning Briefing: S&P 500 Futures -2-
morningstar.com - October 4 at 8:12 AM
Pro-Dexs (NASDAQ:PDEX) Returns Have Hit A WallPro-Dex's (NASDAQ:PDEX) Returns Have Hit A Wall
finance.yahoo.com - August 7 at 7:33 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

LENSAR logo

LENSAR

NASDAQ:LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Nephros logo

Nephros

NASDAQ:NEPH
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.